Portal Veterinary medicinal products

To mark European Antibiotic Awareness Day, we are publishing the 2023 results from the monitoring of sales of veterinary medicines and antibiotic resistance of pathogenic bacteria in animals.

The availability of GS-441524 by pharmacies has raised questions. The French agency for veterinary medicinal products (ANMV) has long been involved in the issue of the therapeutic gap related to feline infectious peritonitis (FIP), in collaboration with the Monitoring committee for veterinary medicinal products. In particular, it has worked to ensure that the use of Remdesivir is not excluded in veterinary medicine at European level. At the same time, the ANMV informed stakeholders of the various legal gateways to therapeutic solutions, including dispensers' preparations.

SENVELGO® (velagliflozin) 15 mg/ml - oral solution for cats - has been granted a marketing authorisation by the European Commission in November 2023. At the request of the European Medicines Agency and, for France, the National agency for veterinary medicinal products, Boehringer Ingelheim Vetmedica GmbH disseminates information on the occurrence of serious adverse reactions and how to prevent them.

Birds of prey and other scavenging animals may accidentally be exposed to veterinary medicines when they eat the carcasses of animals that are not rendered and have therefore been left in the wild. Certain anti-inflammatories and barbiturates pose a particular risk. The French Agency for Veterinary Medicinal Products (ANMV) is calling on veterinarians and breeders to take all the necessary precautions when administering these drugs to animals liable to be consumed by scavengers after their death.